IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

PTC Therapeutics Inc

CUSIP: 69366JAD3 | TRACE | 47 institutional holders

Quarters

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2026

DeepCurrents Investment Group LLC16,343,000
0.8% of portfolio›$25.5M
Ovata Capital Management Ltd14,080,000
1.6% of portfolio›$21.8M
CSS LLC12,002,000
0.7% of portfolio›$18.6M
Capstone Investment Advisors, LLC8,200,000
0.0% of portfolio›$13.0M
FMR LLC2,987,000
0.0% of portfolio›$4.7M
Lazard Asset Management LLC2,188,000
0.0% of portfolio›$34.7K
Bank of New York Mellon Corp200,000
0.0% of portfolio›$326.4K
Morgan Stanley53,000
0.0% of portfolio›$83.7K
StyleTurnoverLocationFiled
DeepCurrents Investment Group LLC
16,343,000$25.5M0.8%GARPHighNew York, NY2026-08-14
Ovata Capital Management Ltd
14,080,000$21.8M1.6%ValueVery HighHong Kong, South Korea2026-07-30
CSS LLC
12,002,000$18.6M0.7%Deep ValueHighChicago, IL2026-08-14
Capstone Investment Advisors, LLC
8,200,000$13.0M0.0%GrowthVery HighNew York, NY2026-08-17
FMR LLC
2,987,000$4.7M0.0%GrowthMediumBoston, MA2026-08-13
Lazard Asset Management LLC
2,188,000$34.7K0.0%CoreMediumNew York, NY2026-08-14
Bank of New York Mellon Corp
200,000$326.4K0.0%CoreLowNew York, NY2026-08-06
Morgan Stanley
53,000$83.7K0.0%CoreLowNew York, NY2026-08-13